Related Experiment Video
Updated: Oct 16, 2025
09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
27.3K
Associations Between Obesity and Pediatric Foot Dimensions
Journal of the American Podiatric Medical Association
|October 21, 2021
Summary
Childhood obesity is linked to smaller foot dimensions in children. This study found that both obese and non-obese children had significantly different foot lengths and widths, impacting pediatric foot health.
Area of Science:
- Pediatric Orthopedics
- Biometrics
- Public Health
Background:
- The impact of childhood obesity on pediatric foot morphology is not well-established.
- Understanding these relationships is crucial for pediatric foot health assessments.
Purpose of the Study:
- To investigate the association between childhood obesity and pediatric foot dimensions.
- To determine if weight category influences foot length and foot width in children.
Main Methods:
- Retrospective analysis of foot dimensions (foot length and foot width) in 3,713 children (ages 3-18).
- Logistic regression analysis was employed to correlate foot dimensions with weight categories.
Main Results:
- Obese boys had significantly longer and wider feet compared to typical weight and underweight boys.
- Obese girls also exhibited significantly longer and wider feet compared to typical weight and underweight girls.
Conclusions:
- Childhood obesity is a significant factor influencing pediatric foot dimensions.
- Findings suggest potential population-wide implications for pediatric foot health due to the prevalence of childhood obesity.
Related Concept Videos
01:24Obesity
718
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
718
01:21Drug Dosing: Obese Patients
17
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
17
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
21
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
21
01:18Polygenic Traits
67.0K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
67.0K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
25
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
25
01:10Nature and Nurture
21.1K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
21.1K